Follow
Josep M Llovet
Josep M Llovet
Prof. of Medicine - Director M Sinai Liver Cancer Prog/ Prof of Research ICREA, BCLC group
Verified email at clinic.cat - Homepage
Title
Cited by
Year
[275] SEQUENCING OF HVRII AND HVRIII OF MITOCHONDRIAL DNA ALLOWS THE DISTINCTION BETWEEN DISSEMINATED AND SYNCHRONIC HEPATOCELLULAR CARCINOMA (HCC)
M Varela, L Boix, M Sole, A Forner, AJ Hessheimer, JM Llovet, J Bruix
Journal of Hepatology, S110, 2007
2007
0915-0940 TBD 0940-1000 Coffee break/Poster viewing
M Kudo, G Abou-Alfa, O Baatarkhuu, RN Chien, JW Park, B Sangro, ...
Surgery 1555, 1615, 0
1016 Diagnosis of hepatocellular carcinoma (hcc)≤ 2 cm: prospective validation of glypican 3, heat-shock protein 70 and glutamine synthetase s taining in biopsy samples
S Tremosini, A Forner, L Boix, J Rimóla, CR de Lope, M Reig, L Bianchi, ...
Journal of Hepatology, S404, 2011
22011
1016TiP LEAP-012 trial in progress: Pembrolizumab plus lenvatinib and transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma (HCC …
JM Llovet, AB El-Khoueiry, A Vogel, DC Madoff, RS Finn, S Ogasawara, ...
Annals of Oncology 31, S702-S703, 2020
82020
1031 FUNCTIONAL ROLE OF B CELLS DURING DEVELOPMENT AND PROGRESSION OF HEPATOCELLULAR CARCINOMA
ML Berres, S Toffanin, C Aloman, JM Llovet, M Merad
Journal of Hepatology, S424, 2013
2013
1057 PLASMA BIOMARKERS AS PREDICTORS OF OUTCOME IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: RESULTS FROM THE RANDOMIZED PHASE III SHARP TRIAL
J Llovet, C Pena, M Shan, C Lathia, J Bruix
Journal of Hepatology, S385, 2009
82009
1092 DISCOVERY OF NOVEL KINASE INHIBITORS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA
S Toffanin, L Cabellos, H Dong, C Alsinet, A Harrington, H Cornella, ...
Journal of Hepatology, S446-S447, 2013
2013
110 MOLECULAR AND CLINICAL CHARACTERIZATION OF RICTOR (MTORC2) AS A CANDIDATE ONCOGENE IN HEPATOCELLULAR CARCINOMA
A Villanueva, H Cornella, V Tovar, C Alsinet, D Chiang, J Peix, B Minguez, ...
Journal of Hepatology, S45, 2009
2009
122 GENOME-BASED MODELING PROGNOSIS IN HEPATOCELLULAR CARCINOMA: PROLIFERATION-G3 AND ADJACENT POOR SIGNATURES INDEPENDENTLY PREDICT RECURRENCE
A Villanueva, Y Hoshida, V Tovar, D Sia, H Cornella, C Alsinet, J Peix, ...
Journal of Hepatology, S54, 2010
2010
1250 Predictors of drop-out and survival of patients with hepatocellular carcinoma candidates for liver transplantation
JM Llovet, M Sala, J Fuster, M Navasa, F Pons, M Solé, C Ayuso, ...
Hepatology, 763, 2003
172003
126 Complications in the donor after right-lobe adult living donor liver transplantation (LDLT)
J Ferrer, J Fuster, R Charco, E Bombuy, C Fondevila, G Alvarez, ...
Journal of Hepatology, 45, 2004
2004
133 DYSREGULATION OF FIBROBLAST GROWTH FACTOR NETWORK IN EARLY HEPATOCELLULAR CARCINOMA
V Tovar, H Cornelià, Y Hoshida, S Toffanin, A Villanueva, D Sia, J Peix, ...
Journal of Hepatology, S58-S59, 2011
2011
155. Tumor Necrosis In Vivo Caused by a Novel Combination of Sorafenib and Rapamycin: Targeting the RAS and Motor Pathways ION Hepatocellular Carcinoma
PH Newell, A Villanueva, J Peix, S van Laarhoven, I Fiel, S Thung, ...
Journal of Surgical Research 144 (2), 245-246, 2008
2008
2 DISRUPTION OF IGF SIGNALING IN EARLY HEPATOCELLULAR CARCINOMA AND PRE-CLINICAL EFFICACY OF ANTI-IGF1R BLOCKING THERAPIES
V Tovar, C Alsinet, L Cabellos, M Sole, A Villanueva, D Chiang, S Moyano, ...
Journal of Hepatology, S3, 2008
22008
223 Preclinical assessment of nintedanib for chemoprevention in hepatocellular carcinoma
V Tovar, A Moeini, S Torrecilla, M Higuera, J Peix, IM Quetglas, ...
European Journal of Cancer, 75, 2014
2014
226 EFFICACY AND SAFETY OF SORAFENIB AT LONG TERM IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): NEED TO SCREEN FOR CARDIOVASCULAR EVENTS AFTER LONG TERM ADMINISTRATION
M Reig, A Forner, CR de Lope, J Rimola, S Tremosini, C Mestres, ...
Journal of Hepatology, S95-S96, 2010
22010
227 CHANGES IN TUMOR BLOOD VOLUME AND PERFUSION ASSESSED PERFUSION COMPUTED TOMOGRAPHY PREDICT THE TIMING OF TUMOR PROGRESSION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED …
M Reig, J Rimola, A Forner, CR de Lope, S Tremosini, C Ayuso, JM Llovet, ...
Journal of Hepatology, S96, 2010
2010
24 A NOVEL MOLECULAR CLASSIFICATION OF HCV-RELATED HEPATOCELLULAR CARCINOMA (HCC) BASED ON INTEGRATIVE GENOMIC ANALYSIS
DY Chiang, A Villanueva, Y Hoshida, J Peix, P Newell, B Minguez, ...
Journal of Hepatology 48 (2), S12, 2008
22008
261 Exclusion of subcapsular tumors prevents peritoneal seeding in hepatocellular carcinoma (HCC) patients treated with radiofrequency
F Pons, M Squarcia, R Vilana, M Sala, L Bianchi, MC Ayuso, M Varela, ...
Journal of Hepatology, 82, 2004
2004
273 Usefulness of sonovue microbubble-enhanced ultrasonography in the assessment of the efficacy of percutaneous ablation in patients with hepatocellular carcinoma
M Varela, R Vilana, L Bianchi, MA Garcia, C Nicolau, M Sanchez, ...
Journal of Hepatology, 85, 2004
22004
The system can't perform the operation now. Try again later.
Articles 1–20